Kevin Conroy Exact Sciences Salary As Chairman President and Chief Executive Officer at EXACT SCIENCES CORP Kevin Conroy made 16 119 899 in total compensation Of this total 1 041 700 was received as a salary 1 920 277 was received as a bonus 0 was received in stock options 12 976 236 was awarded as stock and 181 686 came from other types of compensation
Kevin Conroy made 14 632 240 in total compensation as Chairman of the Board President and Chief Executive Officer at Exact Sciences Corp in 2021 2 229 539 was received as Total Cash 12 266 752 was received as Equity and 135 949 was received as Pension and other forms of compensation This information is derived from proxy statements filed for the 2021 fiscal year Insiders trading at Exact Sciences Over the last 21 years insiders at Exact Sciences have traded over 118 141 352 worth of Exact Sciences stock and bought 191 930 units worth 1 451 887 The most active insiders traders include Kevin T Conroy Edwin M Jr Kania and Maneesh Arora On average Exact Sciences executives and independent directors trade stock every 12 days with the average trade
Kevin Conroy Exact Sciences Salary
Kevin Conroy Exact Sciences Salary
https://intelligencepharma.files.wordpress.com/2018/08/download3.jpg
Exact Sciences Appoints Jeff Elliott Chief Financial Officer Exact
https://d2ft3j3kbsqj8w.cloudfront.net/-/media/Project/ExactCore/Images/Newsroom/elliott.jpg?rev=fde068782e8b4b259c34eda6d7a0d7b6&w=750&hash=31576C5FB38E2FCAFB2B8AB2D222A7DD
New Colon Cancer Screening Less Invasive
https://image.cnbcfm.com/api/v1/image/100652693-73f83923b3c088d1df5de454b26d08ede51cbfda.jpg?v=1529462083&w=1920&h=1080
The estimated Net Worth of Kevin T Conroy is at least 63 Million dollars as of 22 May 2024 Mr Conroy owns over 660 units of Exact Sciences stock worth over 38 861 and over the last 15 years he sold EXAS stock worth over 44 264 698 In addition he makes 18 716 500 as Chairman of the Board President and Chief Executive Officer at Exact Exact Sciences CEO Kevin Conroy 20 121 254 Conroy s base salary was temporarily reduced in early 2020 when the pandemic hit but has since been reinstated at its full amount
Management criteria checks 3 4 Exact Sciences CEO is Kevin Conroy appointed in Apr 2009 has a tenure of 15 33 years total yearly compensation is 16 12M comprised of 6 5 salary and 93 5 bonuses including company stock and options directly owns 0 39 of the company s shares worth 41 87M The average tenure of the management team Kevin Conroy became CEO of Exact Sciences in 2009 and Chairman in 2014 transforming the organization into one of the world s premier cancer diagnostics companies with more than 6 500 employees Under his leadership Exact Sciences is working to change the future of cancer care through innovative tests that help prevent cancer detect it
More picture related to Kevin Conroy Exact Sciences Salary
FDA Approves Expansion Of Cologuard At home Colon Cancer Screening
http://media.foxbusiness.com/BrightCove/854081161001/201909/1104/854081161001_6088668843001_6088677251001-vs.jpg
Leadership Lessons From Exact Sciences CEO Kevin Conroy Exact Sciences
https://d2ft3j3kbsqj8w.cloudfront.net/-/media/Project/ExactCore/Images/Newsroom/Kevin_leadership_lessons.jpg?rev=37cc7dfe4cbc42739c6b5e9b57d748b5&w=1875&hash=16A661F365C7A1EC26525211D72B8E38
CEO Of Exact Sciences Kevin Conroy Is Photographed For Forbes News
https://media.gettyimages.com/photos/of-exact-sciences-kevin-conroy-is-photographed-for-forbes-magazine-on-picture-id1020142676
Tomasz Beer Chief Medical Officer Multi Cancer Early Detection Steven Bellamy Chief Medical Officer International Paul Limburg Chief Medical Officer Screening Our management team led by CEO and President Kevin Conroy guides Exact Science s efforts to provide the best colorectal cancer screening tests treatment guidance and monitoring Kevin T Conroy is Chairman President CEO at Exact Sciences Corp See Kevin T Conroy s compensation career history education memberships
In 2016 Kevin T Conroy earned a total compensation of 3 2M as Chairman President and Chief Executive Officer at Exact Sciences a 43 decrease compared to previous year Exact Sciences Corporation NASDAQ EXAS Q1 2021 Earnings Conference Call May 4 2021 5 00 PM ETCompany Participants Erik Holznecht IR Kevin Conroy Chairman and CEO Jeff Elliott CFO
Colorectal Cancer Screening Test Earns Positive Review From BCBSA
https://clpmag.com/wp-content/uploads/2015/05/Photo-ConroyKevin_Exact-Sciences.jpg
Kevin Conroy CEO Of Exact Sciences NASDAQ EXAS Interview Clear
https://i.ytimg.com/vi/RPf3q1xzrng/maxresdefault.jpg
Kevin Conroy Exact Sciences Salary - Kevin Conroy the CEO president and chairman of Madison based cancer diagnostics firm Exact Sciences Corp spoke with Milwaukee Business Journal editor in chief Mark Kass on Aug 27 about